Results 111 to 120 of about 275,080 (334)
British Journal of Clinical Pharmacology, EarlyView.People accessing aged care services are increasingly older and often experience multimorbidity and polypharmacy, which puts them at risk of medication‐related harm. Quality indicators (QIs) can assist with monitoring, benchmarking and informing initiatives to reduce medication‐related harm.
Daria S. Gutteridge +20 more
wiley +1 more source
European PsychiatryBackground Despite uncertain benefits, antidepressants are used in the management of personality disorders (PDs). We investigated the association between antidepressants and two adverse outcomes - suicidal behaviour and violent crimes - in individuals ...
Kimmo Herttua +3 more
doaj +1 more source
Controlled Assessment of Antidepressant Drugs, Including Tofrānil [PDF]
, 1959 John W. Lovett Doust +4 more
openalex +1 more source
Cognitive behavior therapy in panic disorder and comorbid major depression - A naturalistic study [PDF]
, 2000 Background: There is a lack of evidence about the effectiveness of cognitive behavior therapies (CBT) in settings of routine clinical care as well as in the treatment of panic and comorbid disorders. Methods: We investigated a group-oriented CBT approach
Auer, Claudia +3 more
core +1 more source
Enhancing patient stratification methods for medication review during acute admissions
British Journal of Clinical Pharmacology, EarlyView.Medication review in the hospital is an effective tool for identifying inappropriate prescribing, but not every patient can receive one due to resource constraints. Thus, it is important to identify patients who stand to benefit most from medication review.
Louise Westberg Strejby Christensen +6 more
wiley +1 more source
Antagonism of reserpine‐induced emesis in pigeons: a screening method for antidepressant activity [PDF]
, 1968 K.N. DHAWAN, G.P. Gupta, B.P. JAJU
openalex +1 more source
Biomedicine & Pharmacotherapy, 1996 A common action of many antidepressants is the inhibition of the reuptake of the biogenic amines norepinephrine, serotonin (5-HT) and/or dopamine into nerve terminals. Another postulated mechanism of action for many antidepressants is the downregulation of beta-adrenergic receptors postsynaptically after chronic administration.
M Bourin, GB Baker
openaire +3 more sources
Serotonin reuptake inhibitors and cardiovascular disease [PDF]
, 2005 Selective serotonin re-uptake inhibiting drugs (SSRIs) are widely used for endogenous depression. In addition to depleting the nerve terminals of serotonin they also lower blood platelet serotonin levels.
Belcher, P.R. +2 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims Globally, Australia has the highest per capita consumption rate of pregabalin, commonly prescribed for neuropathic pain. Emerging evidence suggests pregabalin may be associated with the onset or recurrence of several potentially life‐threatening psychiatric events in some individuals.
Amy G. McNeilage +4 more
wiley +1 more source
Therapeutic Advances in Chronic Disease, 2019 Background: Dementia prevalence is increasing worldwide, and dementia is frequently comorbid with depression during its disease course. Additionally, safety concerns are rising regarding the prescription of psychotropic agents to patients with dementia ...
Jian-An Su +5 more
doaj +1 more source